Cowin Venture logo

Cowin Venture

Asia, Beijing, China, Beijing

Description

Cowin Capital, often referred to as Cowin Venture, stands as a well-established venture capital firm in China, primarily headquartered in Shenzhen. Founded in 2000, the firm has built a significant presence in the Chinese investment landscape over two decades. It operates with a broad mandate, encompassing investments across various stages from early-stage and growth-stage companies to pre-IPO opportunities. This strategic flexibility allows Cowin Capital to support companies throughout their lifecycle, from initial development to market leadership.

The firm's investment strategy is primarily focused on high-growth sectors critical to China's economic transformation. Its core areas of interest include Technology, Media, and Telecommunications (TMT), Healthcare, New Energy, and Advanced Manufacturing. Within these sectors, Cowin Capital seeks companies demonstrating strong innovation, significant market potential, and robust management teams. Their diversified sector focus enables them to capitalize on emerging trends and contribute to the development of key industries.

Cowin Capital manages substantial assets, with over $1.4 billion in assets under management across multiple funds. This considerable capital base underpins its ability to make significant investments. The firm boasts an active portfolio, having completed over 120 investments and achieved more than 40 successful exits, underscoring its track record of identifying and nurturing successful ventures. For instance, its Cowin Capital Fund V, launched in 2020, successfully raised approximately 2.5 billion RMB, further solidifying its capacity for new investments.

Given its extensive fund sizes and multi-stage investment approach, Cowin Capital's typical first cheque sizes vary considerably. For early-stage opportunities, initial investments generally range from $1 million to $5 million, providing crucial seed or Series A capital. However, for more mature growth-stage or pre-IPO companies, the firm is capable of deploying significantly larger amounts, with first cheques potentially reaching up to $50 million or more, reflecting its capacity to lead substantial funding rounds.

Investor Profile

Cowin Venture has backed more than 24 startups, with 8 new investments in the last 12 months alone. The firm has led 7 rounds, about 29% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series E rounds (top funding stages).
  • Majority of deals are located in United States, China, Hong Kong.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 1 rounds in the past year.
  • Typical check size: $1M – $50M.

Stage Focus

  • Series A (46%)
  • Series B (25%)
  • Series E (8%)
  • Seed (8%)
  • Series Unknown (4%)
  • Angel (4%)
  • Series C (4%)

Country Focus

  • United States (54%)
  • China (42%)
  • Hong Kong (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Health Diagnostics
  • Clinical Trials
  • Biopharma
  • Cloud Computing
  • Pharmaceutical
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cowin Venture frequently co-invest with?

Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
Casdin Capital
North America, New York, United States, New York
Co-Investments: 3
Gamma3
South America, Parana, Brazil, Curitiba
Co-Investments: 2
Agilent Technologies
North America, California, United States, Santa Clara
Co-Investments: 2
Exact Sciences
North America, Wisconsin, United States, Madison
Co-Investments: 2
Biomatics Capital Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Berkeley Catalyst Fund (BCF)
North America, California, United States, San Francisco
Co-Investments: 3
Camden Partners
North America, Maryland, United States, Baltimore
Co-Investments: 2
Section 32
North America, California, United States, San Diego
Co-Investments: 3
Invus
North America, New York, United States, New York
Co-Investments: 2

Which angels does Cowin Venture often collaborate with?

JS
North America, California, United States, Santa Barbara
Shared Deals: 1
MR
North America, California, United States, San Diego
Shared Deals: 1

What are some of recent deals done by Cowin Venture?

BioTroy Therapeutics

Lingan, Zhejiang, China

BioTroy Therapeutics is a biopharmaceutical company that treats cancer and immunological disorders.

Health CareHealth DiagnosticsMedical
Series AJun 17, 2025
Amount Raised: $27,850,499
Arima Genomics

San Diego, California, United States

Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.

BiotechnologyHealth CareLife ScienceMedical
Series CJun 17, 2025
Amount Raised: $22,000,000
Meraki

Kwun Tong, Kowloon, Hong Kong

Meraki focuses on the European and American markets, and its products meet the needs of home coffee making.

CoffeeManufacturing
AngelApr 15, 2025
Fluoever

Jinshan, Shanghai, China

Fluoever manufactures high-performance fluorine-containing thin film solutions.

ManufacturingSemiconductor
Series AJan 20, 2025
Fine Vision

Nanjing, Jiangsu, China

Fine Vision is a provider of solutions for ophthalmic illnesses.

EyewearHealth CareMedical
Series AJan 16, 2025
Guanchen Biotechnology

Huzhou, Zhejiang, China

Guanchen Biotechnology is a developer of innovative cosmetic ingredients.

BeautyBiotechnologyCosmetics
SeedDec 5, 2024
Yisheng Microna

Wuxi Shi, Jiangsu, China

Yisheng Microna is an ultrasonic transducer designer and developer, focusing on minimally invasive interventional ultrasonography catheters.

Health CareMedicalMedical Device
Series ANov 15, 2024
Sniper Medical Technology

Suzhou, Jiangsu, China

Sniper develops accurate and intelligent molecular diagnostic solutions.

BiotechnologyGeneticsHealth CareHealth DiagnosticsLife ScienceMedical
Series BOct 31, 2024
Amount Raised: $17,978,538
Myrobalan Therapeutics

Medford, Massachusetts, United States

Myrobalan Therapeutics is a biotech firm that develops oral neurorestorative therapies to reverse key brain dysfunctions and CNS conditions.

BiotechnologyHealth CareTherapeutics
Series AJan 10, 2024
Amount Raised: $24,000,000
Jade Bird Display

Shanghai, Shanghai, China

Jade Bird Display is a manufacturer focused on R&D and the development of the smallest, brightest, and most efficient micro-display panels.

Consumer ElectronicsElectronicsManufacturingSemiconductor
Series AAug 10, 2022